Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc R Mansour

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|November 23, 2019
Rapid clinical response to adjuvant corticosteroids in chronic disseminated candidiasis complicated by granulomas and persistent fever in acute leukemia patientsThomas A Fox, Richard Halsey, Sabine Pomplun, et al.
Hemasphere|November 15, 2019
Intensive Chemotherapy Is Associated With Poor Overall Survival in Autoimmune Disease-associated Myeloid MalignanciesSimon E Richardson, Duncan Brian, Victoria Grandage, et al.
Blood|December 17, 2008
Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALLWendy R Gordon, Monideepa Roy, Didem Vardar-Ulu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Notch-1 mutations are secondary events in some patients with T-cell acute lymphoblastic leukemiaMarc R Mansour, Veronique Duke, Letizia Foroni, et al.
British Journal of Haematology|January 5, 2020
In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9 mutationCatherine Hockings, Satyen Gohil, Robin Dowse, et al.
Leukemia|May 30, 2019
The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemiaElena Armenteros-Monterroso, Lu Zhao, Luca Gasparoli, et al.
Blood Advances|December 3, 2025
Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activityThomas Lefeivre, Theodora-Ioana Grosu, Cosmin Tudose, et al.
Nature Cancer|April 15, 2024
Author Correction: Breaking the performance ceiling for neoantigen immunogenicity predictionHugh O'Brien, Max Salm, Laura T Morton, et al.
Blood Advances|February 24, 2026
Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activityThomas Lefeivre, Theodora-Ioana Grosu, Cosmin Tudose, et al.
Disease Models & Mechanisms|May 9, 2019
Disruption of <i>asxl1</i> results in myeloproliferative neoplasms in zebrafishEvisa Gjini, Chang-Bin Jing, Ashley T Nguyen, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|November 23, 2019
Rapid clinical response to adjuvant corticosteroids in chronic disseminated candidiasis complicated by granulomas and persistent fever in acute leukemia patientsThomas A Fox, Richard Halsey, Sabine Pomplun, et al.
Hemasphere|November 15, 2019
Intensive Chemotherapy Is Associated With Poor Overall Survival in Autoimmune Disease-associated Myeloid MalignanciesSimon E Richardson, Duncan Brian, Victoria Grandage, et al.
Blood|December 17, 2008
Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALLWendy R Gordon, Monideepa Roy, Didem Vardar-Ulu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Notch-1 mutations are secondary events in some patients with T-cell acute lymphoblastic leukemiaMarc R Mansour, Veronique Duke, Letizia Foroni, et al.
British Journal of Haematology|January 5, 2020
In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9 mutationCatherine Hockings, Satyen Gohil, Robin Dowse, et al.
Leukemia|May 30, 2019
The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemiaElena Armenteros-Monterroso, Lu Zhao, Luca Gasparoli, et al.
Blood Advances|December 3, 2025
Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activityThomas Lefeivre, Theodora-Ioana Grosu, Cosmin Tudose, et al.
Nature Cancer|April 15, 2024
Author Correction: Breaking the performance ceiling for neoantigen immunogenicity predictionHugh O'Brien, Max Salm, Laura T Morton, et al.
Blood Advances|February 24, 2026
Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activityThomas Lefeivre, Theodora-Ioana Grosu, Cosmin Tudose, et al.
Disease Models & Mechanisms|May 9, 2019
Disruption of <i>asxl1</i> results in myeloproliferative neoplasms in zebrafishEvisa Gjini, Chang-Bin Jing, Ashley T Nguyen, et al.
Pageof 7